Report Overview
The Global Type II Collagen Market reached US$ 214.48 million in 2023 and is expected to reach US$ 302.92 million by 2031, growing at a CAGR of 4.41% during the forecast period 2024-2031.
As the aging population grows globally, there is an increasing awareness of joint health and mobility issues. Type II collagen, known for its ability to support cartilage and joint function, is seeing heightened demand. The trend drives global type II collagen market expansion, particularly among elderly consumers and individuals with active lifestyles who prioritize joint health.
According to the World Health Organization, countries face significant challenges in preparing their health and social systems for the rapid demographic shift toward an aging population. By 2050, it is projected that 80% of older adults will reside in low- and middle-income countries and the pace of population aging is accelerating at an unprecedented rate.
In 2020, for the first time, the number of people aged 60 years and older surpassed the number of children under the age of five. Furthermore, between 2015 and 2050, the proportion of the global population over 60 will nearly double, increasing from 12% to 22%. This demographic change requires urgent action to adapt healthcare and social support systems to the needs of older individuals.
Market Scope
| Metrics | Details |
| CAGR | 4.41% |
| Size Available for Years | 2022-2031 |
| Forecast Period | 2024-2031 |
| Data Availability | Value (US$) |
| Segments Covered | Form, Source, Application and Region |
| Regions Covered | North America, Europe, Asia-Pacific, South America and Middle East & Africa |
| Fastest Growing Region | Asia-Pacific |
| Largest Region | North America |
| Report Insights Covered | Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and Acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, Porter’s Analysis, Pricing Analysis, Regulatory Analysis, Supply-Chain Analysis and Other key Insights. |
For more details on this report - Request for Sample
Market Dynamics
Rising Prevalence of Osteoarthritis
As osteoarthritis becomes more common, especially among the aging population, the demand for effective treatments and joint health supplements significantly increases. Type II collagen, known for its role in supporting joint health and reducing inflammation, is increasingly being incorporated into dietary supplements, functional foods and pharmaceuticals to address the growing needs of those affected by this condition.
For instance, according to the Osteoarthritis (OA) Action Alliance, the prevalence of OA varies by age, gender and ethnicity. Age-wise, 43% of individuals with OA are 65 or older and 88% are 45 or older. The highest annual incidence of knee OA occurs between the ages of 55 and 64, although more than half of those with symptomatic knee OA are under 65. Gender differences show that 62% of individuals with OA are women. While OA is more common in men under 45, it becomes more prevalent in women after that age. In terms of ethnicity, 78% of those with OA are non-Hispanic whites.
Growing Interest in Sports Nutrition
The growing interest in sports nutrition is expected to drive the global type II collagen market significantly. As athletes and fitness enthusiasts increasingly focus on joint health, recovery and performance enhancement, type II collagen is gaining attention for its potential benefits in supporting joint integrity, reducing inflammation and promoting cartilage repair, driving the market growth.
The market is witnessing a rise in demand for collagen-based supplements, especially from individuals engaged in high-impact sports. These consumers seek products that can help maintain their joint health and prevent injury, contributing to the expansion of the type II collagen segment within the broader Sports Nutrition Market. This trend is further supported by the growing awareness of collagen's role in improving mobility and flexibility, making it a key ingredient in the market for sports supplements and functional foods.
According to Bulk CEO, the rising popularity of strength training has propelled the direct-to-consumer (DTC) nutrition brand to a record-breaking performance, with revenues surging by 30% to EUR 123.1 million in 2023. Strong customer retention and record-high new customer acquisition were key drivers behind this growth. Bulk added nearly 800,000 new customers last year and sold over nine million products, with clear whey protein emerging as the fastest-growing line and the value essentials range performing well amid the cost of living crisis.
Creatine products remained popular among customers focused on muscle mass building, while collagen and magnesium products saw increased demand as recovery solutions. Bulk’s impressive revenues boosted adjusted EBITDA to EUR 9.3 million, up from EUR 2.6 million in 2022 and pre-tax profits rose to EUR 6 million, compared to just EUR 66k the previous year, despite inflation-driven ingredient cost hikes.
Vegan and Ethical Concerns
As consumer demand shifts towards plant-based and cruelty-free products, a growing segment of the market is becoming increasingly wary of products derived from animal sources, such as type II collagen, which is typically sourced from chicken sternum or other animal tissues. This ethical stance, combined with the rising vegan population globally, may hinder the growth of the type II collagen market, as consumers seek alternative, plant-based solutions for joint health and skin care.
Moreover, the type II collagen market is also likely to face challenges as brands navigate the ethical debates around animal welfare and sustainability. The production methods for animal-derived collagen are often scrutinized for their environmental impact, which can further dampen demand in markets where sustainability and ethical sourcing are high priorities, restraining market growth.
Market Segment Analysis
The global type II collagen market is segmented based on form, source, application and region.
Rising Consumer Demand for Type II Collagen Skin Health Products
The cosmetics segment holds the largest share of the global type II collagen market due to a combination of rising consumer demand for skin health products and the increasing awareness of collagen's role in enhancing skin elasticity, hydration and overall appearance. As consumers become more focused on maintaining a youthful appearance, there is a surge in the popularity of anti-aging products, with type II collagen becoming a key ingredient.
The growing demand for anti-aging and skin-rejuvenating solutions is driving the cosmetics market forward with type II collagen’s proven benefits. The cosmetics industry is continually evolving with innovative product formats such as collagen-infused masks, lotions and ingestible beauty supplements. For instance, on January 24, 2023, Geltor expanded into the hair care market with the launch of NuColl, a vegan collagen produced through fermentation.
Market Geographical Share
Increasing Prevalence of Joint Disorders in North America
North America is expected to dominate the global type II collagen market. The primary driver is the region's rapidly aging population, which is leading to an increasing prevalence of joint disorders such as osteoarthritis. This is creating significant demand for joint health supplements, where type II collagen is widely used for its potential to support cartilage and improve joint function.
Growing consumer awareness about the benefits of collagen supplements, driven by extensive marketing efforts and strong distribution channels, is contributing to market expansion in North America. The region also benefits from a highly developed healthcare infrastructure and a robust dietary supplement market, allowing for easier access to collagen-based products. These trends, along with a focus on product innovation and new formulations, are helping North America maintain its leading position in the global type II collagen market.
Market Competitive Landscape
The major global players in the market include Ashland Inc., Athos Collagen Private Limited, Chondrex, Inc., Advanced BioMatrix, Rousselot, Takara Bio Inc., SouthernBiotech, REPROCELL Inc., KOKEN CO., LTD. and JINBO BIO-PHARMACEUTICAL CORPORATION LIMITED.
Russia-Ukraine War Impact Analysis
The ongoing Russia-Ukraine war has significantly affected the global type II collagen market, influencing supply chains and consumer behavior. The conflict has disrupted agricultural activities and trade routes in Eastern Europe, leading to shortages and increased prices of key ingredients sourced from the region. This disruption in supply chains has resulted in heightened production costs for manufacturers in the type II collagen market, prompting some companies to pass these costs on to consumers.
The war has contributed to broader economic instability, affecting consumer spending patterns and priorities. In times of uncertainty, consumers may reduce discretionary spending on supplements, including type II collagen products. This could slow market growth as demand fluctuates, especially in regions heavily reliant on imports from affected countries.
By Form
- Dry
- Liquid
By Source
- Bovine
- Porcine
- Poultry
- Others
By Application
- Food and beverage
- Healthcare
- Cosmetics
- Others
By Region
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Rest of Europe
- South America
- Brazil
- Argentina
- Rest of South America
- Asia-Pacific
- China
- India
- Japan
- Australia
- Rest of Asia-Pacific
- Middle East and Africa
Key Developments
- On November 4, 2023, Lee Pharma, a Hyderabad-based pharmaceutical company, received marketing authorization to launch its Bio-Cartilage SmoothWalk tablets in the United Arab Emirates. This milestone marks a significant achievement for the company, as Bio-Cartilage SmoothWalk becomes the first Indian nutraceutical product to be licensed in the UAE.
- On March 3, 2022, ByHealth, a leading vitamin and dietary supplements company in China, introduced a new collagen product under its Highflex joint health brand. This product features Collavant n2, a native (undenatured) type II collagen ingredient from Bioiberica (Barcelona), which has been clinically proven to alleviate knee discomfort and improve joint function.
- On April 20, 2021, Lonza announced the expansion of its UC-II undenatured collagen ingredient line with the launch of a new supplement made from certified organic collagen and verified by the Non-GMO Project. The new UC-II undenatured type II collagen aims to solve this by offering a consumer-friendly, once-daily dose, providing a more convenient option for those in the organic joint-health market.
Why Purchase the Report?
- To visualize the global type II collagen market segmentation based on form, source, application and region, as well as understand key commercial assets and players.
- Identify commercial opportunities by analyzing trends and co-development.
- Excel spreadsheet containing a comprehensive dataset of the type-ii-collagen-market, covering all levels of segmentation.
- PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
- Product mapping available as Excel consisting of key products of all the major players.
The global type II collagen market report would provide approximately 62 tables, 53 figures and 202 pages.
Target Audience 2024
- Manufacturers/ Buyers
- Industry Investors/Investment Bankers
- Research Professionals
- Emerging Companies
